Consultative Hematology

Activity Details
  • Credit Type: CME
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Nov 27, 2018
  • Expires: Nov 27, 2019
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)


Needs Statement

This is a series on topics in cancer care aimed to improve clinician’s knowledge of complex cancer diagnosis and treatment and competence in treating these patients. This series aims to strengthen the partnership between community health centers and academic cancer centers.

Target Audience

Target Audience: Community Health Center Providers


After participating in this activity, participants will be able to:

1) Discuss common hematologic conditions
2) Discuss reasons for hematology consultation
3) Provide easy access to care for hematological conditions at BMC


Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Naomi Ko, MD - Course Director
Dr. Ko has no relevant financial relationships to disclose.

Vaishali Sanchorawala, MD - Faculty
Dr. Sanchorawala has received grant/research support from Celgene, Janssen, Prothena and Takeda.  She does not plan on discussing unlabeled/investigational uses of a commercial products.